Introduction: Research shows marked differences in the prevalence of dementia among different ethnic groups. However, there is a relative dearth of studies focusing on how ethnicity may influence dementia. The main aim of the current study is to test potential mediating effects of depression and level of education on the association between ethnicity and dementia. Methods: The sample for this study, consisting of 2,796 community-dwelling elderly people aged 60 years and older, was drawn from a cross-sectional national survey entitled ‘Mental Health and Quality of Life of Older Malaysians'. The Malaysian adapted version of the Geriatric Mental State-Automated Geriatric Examination for Computer-Assisted Taxonomy was used to assess dementia and depression. Data analysis was conducted using IBM SPSS version 19. Results: As expected, the result of the χ2 analysis revealed significant ethnic difference in the prevalence of dementia (χ2 = 58.05, p ≤ 0.001). The results of the mediational analyses revealed that depression (Z = 4.05, p ≤ 0.001) and education (Z = 2.78, p ≤ 0.01) significantly, but partially, mediate the association between ethnicity and dementia. This suggests that disparities of depressive symptoms and education contribute to ethnic difference in the prevalence of dementia. Conclusions: These findings provide more insight into how ethnicity may influence an individual's vulnerability to dementia. The limitations of the study along with implications of the findings and needs for further study are discussed.

Keywords:
Aged, Dementia, Depression, Education, Ethnicity, Mediational analysis
1.
Bosanquet N: The socioeconomic impact of Alzheimer's disease. Int J Geriatr Psychiatry 2001;16:249-253.
2.
Koch T, Iliffe S, Manthorpe J, Stephens B, Fox C, Robinson L, Livingston G, Coulton S, Knapp M, Chew-Graham C, Katona C: The potential of case management for people with dementia: a commentary. Int J Geriatr Psychiatry 2012, DOI: 10.1002/gps.3783, E-pub ahead of print.
3.
Grant I, Adams KM: Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders. New York, Oxford University Press, 2009.
4.
Rodriguez JJ, Ferri CP, Acosta D, Guerra M, Huang Y, Jacob K, Krishnamoorthy ES, Salas A, Sosa AL, Acosta I: Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet 2008;372:464-474.
5.
Holay MP, Patil PS, Joshi PP, Dube AM, Suryawanshi SD, Waradkar P: Association of impaired cognitive functions with cardiovascular risk factors in elderly Indian population J Assoc Physicians India 2011;59:91-94.
6.
Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F: Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurology 2008;7:812-826.
7.
Allain H, Neuman E, Malbezin M, Salzman V, Guez D, Wesnes K, Gandon J: Bridging study of S12024 in 53 in-patients with Alzheimer's disease. J Am Geriatr Soc 1997;45:125-126.
8.
Demirovic J, Prineas R, Loewenstein D, Bean J, Duara R, Sevush S, Szapocznik J: Prevalence of dementia in three ethnic groups: the South Florida Program on Aging and Health. Ann Epidemiol 2003;13:472-478.
9.
Larson EB, Imai Y: An overview of dementia and ethnicity with special emphasis on the epidemiology of dementia; in Yeo G, Gallagher-Thompson D (eds): Ethnicity and the Dementias. Washington, Taylor & Francis, 1996, pp 9-20.
10.
Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R: The APOE-4 allele and the risk of Alzheimer's disease among African Americans, Whites and Hispanics. JAMA 1998;279:751-755.
11.
Yeo G: Ethnicity and dementia. J Am Geriatr Soc 2001;49:1393-1394.
12.
Lister S, Benson C: Comparative analysis of dementia and ethnicity in the New South Wales Aged Care Assessment Program: 1996 and 2001. Aust J Ageing 2006;25:24-30.
13.
Hamid TA, Krishnaswamy S, Abdullah SS, Momtaz YA: Sociodemographic risk factors and correlates of dementia in older Malaysians. Dement Geriatr Cogn Disord 2010;30:533-539.
14.
Sahadevan S, Saw SM, Gao W, Tan L, Chin JJ, Venketasubramanian N: Ethnic differences in Singapore's dementia prevalence: The Stroke, Parkinson's Disease, Epilepsy, and Dementia in Singapore Study. J Am Geriatr Soc 2008;56:2061-2068.
15.
Manly JJ, Mayeux R: Ethnic differences in dementia and Alzheimer's disease; in Anderson NB, Bulatao RA, Cohen B (eds): Critical Perspectives on Racial Differences in Health in Late Life Washington, National Academic Press, 2004, pp 95-142.
16.
Geda YE: Blowing hot and cold over depression and cognitive impairment. Neurology 2010;75:12-14.
17.
Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF III, DeKosky ST, Becker JT: Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008;10:345-357.
18.
Korczyn AD, Halperin I: Depression and dementia. J Neurol Sci 2009;283:139-142.
19.
Hamid TA, Momtaz YA, Syed Abdul Rashid SN: Older women and lower self-rated health. Educ Gerontol 2010;36:521-528.
20.
Ng TP, Niti M, Chiam PC, Kua EH: Physical and cognitive domains of the instrumental activities of daily living: validation in a multiethnic population of Asian older adults. J Gerontol A Biol Sci Med Sci 2006;61:726-735.
21.
Prince M, Acosta D, Chiu H, Scazufca M, Varghese M: Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003;361:909-917.
22.
Newman SC, Bland RC, Orn HT: The prevalence of mental disorders in the elderly in Edmonton: a community survey using GMS-AGECAT. Can J Psychiatry 1998;43:910-914.
23.
Janzing J, Naarding P, Eling P: Depressive symptoms predict slow cognitive decline in mild dementia. Dement Geriatr Cogn Disord 2005;20:77-81.
24.
Prince M, Acosta D, Chiu H, Copeland J, Dewey M, Scazufca M, Varghese M: Effects of education and culture on the validity of the geriatric mental state and its AGECAT algorithm. Br J Psychiatry 2004;185:429-436.
25.
Frazier PA, Tix AP, Barron KE: Testing moderator and mediator effects in counseling psychology research. J Counsel Psychol 2004;51:115-134.
26.
Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
27.
Momtaz YA, Hamid TA, Yahaya N: The role of religiosity on relationship between chronic health problems and psychological well-being among Malay Muslim older persons. Res J Med Sci 2009;3:188-193.
28.
MacKinnon DP, Dwyer JH: Estimating mediated effects in prevention studies. Eval Rev 1993;17:144-158.
29.
Masel MC, Raji M, Peek MK: Education and physical activity mediate the relationship between ethnicity and cognitive function in late middle-aged adults. Ethn Health 2010;15:283-302.
30.
Sachs-Ericsson N, Blazer DG: Racial differences in cognitive decline in a sample of community-dwelling older adults: the mediating role of education and literacy. Am J Geriatr Psychiatry 2005;13:968-975.
31.
Zsembik BA, Peek MK: Race differences in cognitive functioning among older adults. J Gerontol B Psychol Sci Soc Sci 2001;56:S266-S274.
32.
Hamid TA, Momtaz YA, Ibrahim R: Predictors and prevalence of successful aging among older Malaysians. Gerontology 2012;58:366-370.
33.
Fratiglioni L, Wang HX: Brain reserve hypothesis in dementia. J Alzheimers Dis 2007;12:11-22.
34.
Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A: Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. BMJ 1995;310:970-973.
35.
Zhang M, Katzman R, Salmon D, Jin H, Cai G, Wang Z, Qu G, Grant I, Yu E, Levy P, Klauber MR, Liu WT: The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990;27:428-437.
36.
Orrell M, Sahakian B: Education and dementia. BMJ 1995;310:951-952.
37.
Brayne C, Ince PG, Keage HAD, McKeith IG, Matthews FE, Polvikoski T, Sulkava R: Education, the brain and dementia: neuroprotection or compensation? Brain 2010;133:2210-2216.
38.
Roe CM, Mintun MA, D'Angelo G, Xiong C, Grant EA, Morris JC: Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh compound B uptake. Arch Neurol 2008;65:1467-1471.
39.
Stern Y: What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.
40.
Scarmeas N, Stern Y: Cognitive reserve and lifestyle. J Clin Exp Neuropsychol 2003;25:625-633.
41.
Derouesne C, Lacomblez L: Depression and dementia (in French). Psychol Neuropsychiatr Vieil 2004;2(suppl 1):S35-S42.
42.
Jeffrey S: Depression doubles risk for dementia and Alzheimer's disease. Neurology 2010;75:35-41.
43.
Khaw CR, Teo CW, Rashid AK: Cognitive impairment and depression among residents of an elderly care home in Penang, Malaysia. Internet J Psychiatry 2010;1.
44.
Mathews M, Mathews J: Recognition and treatment of depression in the elderly. Prim Psychiatry 2004;11:33-37.
45.
Geerlings M, Bouter L, Schoevers R, Beekman ATF, Jonker C, Deeg DJH, Van Tilburg W, Adar HJ, Schmand B: Depression and risk of cognitive decline and Alzheimer's disease. Br J Psychiatry 2000;176:568-575.
46.
Eaton WW, Neufeld K, Chen LS, Cai G: A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry 2000;57:217.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.